All sites C00-96,D32-33,D42-43,D45-47,D76 144 90.0 2.5 4.7 0.4 2.4
Mouth, pharynx C00-14 4 100.0 - - - -
  Lip C00 0 100.0 - - - -
  Tongue C02 1 100.0 - - - -
  Mouth, other C03-06 2 100.0 - - - -
  Salivary glands C07-08 0 100.0 - - - -
  Pharynx C01,C09-14 0 100.0 - - - -
Digestive organs C15-26 27 85.4 1.5 8.0 0.7 4.4
  Oesophagus C15 1 100.0 - - - -
  Stomach C16 3 93.8 - - - 6.3
  Small intestine C17 0 100.0 - - - -
  Colon C18 8 100.0 - - - -
  Rectum, rectosigmoid C19-20 4 100.0 - - - -
  Anus C21 0 100.0 - - - -
  Liver C22 2 87.5 - - - 12.5
  Gallbladder, bile ducts C23-24 1 57.1 - 28.6 - 14.3
  Pancreas C25 7 63.9 5.6 19.4 2.8 8.3
  Other digestive organs C26 1 50.0 - 50.0 - -
Respiratory organs C30-39 9 61.4 15.9 15.9 2.3 4.5
  Nose, sinuses C30-31 - - - - - -
  Larynx, epiglottis C32 0 100.0 - - - -
  Lung, trachea C33-34 8 61.9 16.7 14.3 2.4 4.8
  Mediastinum, pleura C38 0 - - 100.0 - -
Bone C40-41 0 50.0 - 50.0 - -
Melanoma of the skin C43 4 100.0 - - - -
Skin, non-melanoma C44 6 100.0 - - - -
Mesothelioma C45 0 100.0 - - - -
Autonomic nervous system C47 - - - - - -
Soft tissues C48-49 1 83.3 - - - 16.7
Breast C50 45 99.1 - - 0.4 0.4
Female genital organs C51-58 18 93.3 2.2 2.2 - 2.2
  Cervix uteri C53 2 87.5 12.5 - - -
  Corpus uteri C54 7 100.0 - - - -
  Uterus, other C55,C58 - - - - - -
  Ovary C56 6 83.9 3.2 6.5 - 6.5
  Other female genital C51-52,C57 3 100.0 - - - -
Urinary organs C64-68 7 94.6 - 5.4 - -
  Kidney C64 5 91.7 - 8.3 - -
  Bladder and urinary tract2 C65-68 3 100.0 - - - -
Eye C69 - - - - - -
Brain, central nervous system C70-72,D32-33,D42-43 5 84.0 - 16.0 - -
Thyroid gland C73 2 100.0 - - - -
Other endocrine glands C74-75 0 100.0 - - - -
Illdefined or unknown C76,C80 3 50.0 21.4 28.6 - -
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 12 79.3 6.9 5.2 - 8.6
  Hodgkin lymphoma C81 0 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 6 100.0 - - - -
  Malignant immunoproliferative diseases C88 - - - - - -
  Myeloma and other plasma cell tumors C90 2 33.3 11.1 33.3 - 22.2
  Leukaemia C91-95 2 66.7 25.0 - - 8.3
  Myelodysplastic syndromes D46 1 100.0 - - - -
  Myeloproliferaitive neoplasms D45,D47 1 33.3 - - - 66.7
Not included above
  Carcinoma in situ of the breast D05 2 100.0 - - - -
  Cervix uteri, non-invasive neoplasms 7 100.0 - - - -
  Borderline tumour of the ovary D39 2 100.0 - - - -
  Basal cell carcinoma of the skin 59 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.